We used plyclonal antisera raised in rabbits against membrane-bound rat lung and human lung carbonic anhydrase (CA) IV in immunofluorescence studies to stain aysections of rat soleus and extensor digitorum longus (EDL) and several human skeletal musdes. There was strong specific staining of capillaries in all musdes investigated. Several techniques were applied to verify this result. (a) Serial sections were either incubated with anti-CA IV/"E or processed for endothelial ATPase reaction. There was precise CO-localization of antibody marked structures and ATPase stained capillaries. (b) Human musde sections were double stained with anti-CA IV/"RIK and anti-von Willebrand factor (vWF)/HK. vWF, a capillary marker, and CA IV were localized at identical sites. (c) The CA IV was released from cap& lark by treatment with phosphatidylinositol specific phospholipase C, suggesting that the enzyme is anchored to the 19. Dubawitz V, Brooke MH. Muscle biopsy. A modern approach. London, Philadelphia, Toronto: WB Saunders, 1973:32 20. Sillau AH, Banchero N. Visualization of capillaries in skeletal muscle by the ATPase reaction. Mugers Arch 1977;369:269 21. Riddenmile Y. Observations on the localization of carbonic anhydrase in muscle. Acta Physiol Scand 1979;106:239 22. Riley DA, Ellis S, Bain J. Carbonic anhydrase activity in skeletal muscle fiber types, axom, spindles and capillaries of rat soleus and extensor digitorum longus muscles. J Histochem Cytochem 1982;301275 23. Lijnnerholm G. Carbonic anhydrase in rat liver and rabbit skeletal muscle; further evidence for the specificity of the histochemical cobaltphosphate method of Hansson.
Introduction
Mammalian skeletal muscle contains at least three types of carbonic anhydrase (CA), the cytosolic isozymes CA I1 and CA I11 and a membrane-bound form (see ref. 1 for review). CA I1 is present in some species in fast muscles, e.g. the extensor digitonun longus (EDL), whereas CA I11 is abundant in slow red muscles such as the M. soleus (2) (3) (4) (5) (6) (7) . Furthermore, a number of histological, biochemical, and physiological studies (8) (9) (10) (11) (12) indicate the existence of a membrane-bound CA in sarcolemma (SL) and sarcoplasmic reticulum (SR) of skeletal muscle cells.
Membrane-bound CA has already been isolated from other tissues, including bovine lung (13) and human kidney (14) . A membrane-bound isozyme was also isolated from rat lung (15) and from human lung and kidney (16) and was identified as CA IV. endothelial cell membrane via a phosphatidylinositolglycan anchor. (d) A rat hindlimb was perfused with diluted antiserum. Cryosections of perfused soleus and EDL processed for anti-rabbit IgG/HK staining showed dear fluorescence associated with capillaries, indicating that the antigen was a d b l e from the capillary lumen. (e) Immune complexes formed during antiserum perfusion as described in d were precipitated from musde homogenates. SDS-PAGE followed by immunoblotring showed that the predominant portion of total musde CA IV was bound in these complexes and therefore must be located intravasdarly. ( J Histochem Rat CA IV was shown to have a molecular mass of 39 KD, which is reduced to 36 KD by treatment with endoglycosidase F, indicating the existence of one N-linked oligosaccharide chain. The 36 KD human CA IV contains no carbohydrate (15) . We report here the localization of membrane-bound CA IV in rat soleus and EDL and in human skeletal muscles, using monospecific antisera against rat lung and human lung CA IV in immunofluorescence studies.
Materials and Methods
Tissue Preparation. Rat muscles were dissected and frozen in liquid nitrogen or liquified propane. Pieces of various human muscles were frozen in liquid nitrogen. Cryosections 5-7 pm thick were cut and fixed in acetone at -20°C for 1 min. They were dried at room temperature (RT) and wrapped in aluminum foil for storage at -20°C.
Immunohistochemisuy. Monospecific antisera against rat lung CA IV and human lung CA IV were raised in rabbits as described (16J7).
Stored cryosections were brought to RT within the aluminum foil. They were then post-fixed in acetone at -2O' C for 10 min and air-dried at RT. To reduce nonspecific binding, the slides were incubated in PBS with 0.5 1229 mglml bovine serum albumin (PBSlBSA) for 30 min. For CA IV staining, sections were incubated with a 1:500 dilution of anti-rat lung CA IV or anti-human lung CA IV serum for 30 min. Control sections were incubated with a 1:500 dilution of rabbit non-immune serum (Sigma; Deisenhofen, Germany) or with PBS, respectively. All slides were washed in PBSlBSA for 30 min, followed by incubation with anti-rabbit IgGIFITC conjugate (Sigma) at 130 dilution for 30 min. After a further 30-min wash in PBSlBSA, the slides were mounted in 20% glycerol in PBS and viewed with a Leitz orthoplan microscope.
For rat muscles, another control was done by pre-absorbing the antiserum with the antigen. Four pg of rat CA IV in PBS was added to 1 pl of undiluted antiserum. The mixture was kept for 24 hr at 4'C and then centrifuged. The supernatant was used at a final dilution of 1:500 instead of the 1:500 diluted antiserum (see above).
Color photography was done with Kodak Ektachrome 400 and blackand-white photography with Ilford HP5 film. Pictures of specific staining and corresponding controls were taken and printed at the same exposure times.
For double staining, human muscle sections were processed for anti-CA IV staining as described above. They were then incubated with antirabbit IgGlTRITC conjugate (Sigma) at 1:30 dilution for 30 min. After a wash in PBSlBSA they were further incubated with monoclonal anti-von Willebrand factor (vWF) (DAKO Diagnostica: Hamburg, Germany) at 1:50 dilution and after another wash in PBSlBSA with anti-mouse IgG FITC conjugate (Sigma) at l:50 dilution, each step for 30 min. They were washed and mounted as described above. This procedure enabled us to localize two different antigens within the same section by consecutive use of two different filter combinations for FITC and TRITC fluorescence.
Eatment of Sections with Phosphatidylinositol-specific Phospholipase C (PI-PK). Before Anti-CA IVlFITC staining, rat soleus sections were incubated with 100 mU PI-PLC (ICN Biomedicals; Costa Mesa, CA) per section for 2 hr at RT (18) . Control sections were incubated with buffer only.
ATPase Staining. The ATPase reaction was performed according to Dubowitz and Brooke (19) . For visualization of capillaries, muscle sections were pre-incubated in acid medium as described by Sillau and Banchero (20), but using pH 4.0-4.1 instead of pH 3.8. The procedure resulted in staining of the capillaries by insoluble dark cobalt sulfide.
Perfusion of Rat Hindlimb. The experiment was performed following the national guidelines for care and use of laboratory animals. Female Wistar rats (approximately 200 g) were anesthetized with 0.2 ml 10% ketamine (WTYI: Hannover, Germany) and 0.15 ml2% Rompun (Bayer; Leverkusen, Germany). Liquemin N 25000 0.2 ml (Hoffmann-La Roche: Grenzach-Wyhlen. Germany) was given IP. Hindlimbs were perfused via the femoral artery, initially with Hanks balanced salt solution (BSS) for 30 min. One hindlimb was then perfused with 6 ml of anti-rat lung CA IV at a dilution of 1:lOO while the hindlimb was gently massaged. The flow was then stopped for 5 min to allow more time for antibody-antigen binding.
After this interval, perfusion was resumed with Hanks BSS for 10 min to wash out unbound antibody. Control perfusion was performed following the same protocol but using rabbit non-immune serum at 1:lOO dilution.
Soleus, EDL, and tibialis anterior (TA) muscles were dissected and frozen in liquid nitrogen. Muscle cryosections from soleus andEDL were cut and processed for FITC staining as described above to visualize the antibodymarked antigen.
Isolation of CA N Immune Complexes from M d e C a p W e s Exposed to Anti-CA N. TA muscle (0.5 g) from rat hindlimb, after having been perfused and frozen in liquid nitrogen as just described, was homogenized in a Brinkmann polytron with 3 volumes of 50 mM ?iis-S04, pH 7.5, containing 1 mM benzamidine and 1% Triton X-114. The supernatant was recovered after centrifugation of the muscle homogenate at 40,000 x g for 60 min. One ml of clear supernatant was mixed with 100 PI of dissolved lyophilized .YtapbyLococcmuurew cell membrane (Staph A, 10% vlv). and incubated overnight at 4°C. Staph A (IgGSorb; Enzyme Center, Malden, MA) easily binds to the k fragment of IgG antibodies and can therefore be used to precipitate antigen-antibody complexes. The Staph A-immune complexes were recovered after 1-min centrifugation in Eppendorf tubes and washed twice with 1 ml of 1:10 diluted PBS. To each of the combined supernatants (including washes) from the initial non-immune serum and antiserum samples, 10 pl rabbit anti-rat lung CA IV was added, followed by 50 pl of Staph A. After another overnight incubation, the Staph A-immune complexes were recovered and washed as described above. The rat CA IV recovered in immune complexes from both precipitation steps was characterized by solubilizing the immune complexes in SDS under nonreducing conditions, sedimenting the Staph A, and subjecting the clear supernatants to SDS-PAGE (12 %) under non-reducing conditions, followed by Western blots as described (18) . Before electrophoretic transfer of the polypeptides from the gel to the membrane, 0.5 cm from the top of the gel was cut out to remove the rabbit immunoglobulin of larger molecular weight. For immunostaining of the transferred polypeptides, rabbit antirat lung CA IV was used at 1:500 dilution, followed by 1:500 diluted goat anti-rabbit IgGlperoxidase-conjugated second antibodies (Sigma). Peroxidase activity was stained with 4-chloro-1-naphthol and H202.
Results

CA IV Is Associated with Capillaries
Rabbit serum was used in the immunohistological studies described here because it gave stronger staining than pusled antibodies. However, incubation of sections with protein G affinity-purified antibodies yielded the same results.
Incubation of soleus muscle sections with anti-CA IV showed clear positive staining of capillaries ( Figure la) . The lumina ofsome of the capillaries were visible, and several capillaries were cut longitudinally. No fluorescence appeared to be associated with the muscle cells themselves. Figure Ib shows a control section of rat soleus incubated with rabbit non-immune serum. Capillaries showed no fluorescence in these controls. This was also true for incubation with PBS in place of the first antibody (not shown). Another control was performed by pre-absorbing the antiserum with the antigen, CA IV, before applying it to the sections. After this treatment there was no longer any specific staining of capillaries (not shown). The fluorescence was reduced to the level of background staining seen with rabbit non-immune serum ( Figure Ib) or PBS. These control experiments suggest that the fluorescence of capillaries shown in Figure la is specific and therefore that CA IV is localized in the muscle capillaries. Waheed et al. ( 1 5~8 ) provided biochemical data that CA IV in mammalian lung and in rat muscle is anchored to membranes by a phosphatidylinositolglycan (GPI) anchor, which is sensitive to phosphatidylinositol-specific phospholipase C. Figure 2a shows a section from rat soleus muscle after PI-PLC treatment and subsequent anti-CA IV/FITC staining. PI-PLC released the antigen from the capillary membranes, resulting in complete absence of staining. Figure 2b is a control to this experiment and shows a section incubated with buffer only instead of PI-PLC before immunostaining. The staining pattern is the same as that shown in Figure la . The experiment shows that the rat muscle CA IV is a GPI-anchored antigen, in agreement with the biochemical data.
To verify that the fluorescent structures are indeed capillaries, one of two serial sections was processed for anti-CA IV staining (Fig- ure 3a) and the other was stained with the acid ATPase reaction (Figure 3b ). There was precise co-localization of anti-CA IV-stained structures and cobalt sulfide-stained capillaries (arrows in Figures  3a and 3b) . The above studies were carried out on soleus, a slow-twitch red muscle. The EDL, a fast-twitch muscle, was also investigated. Immunohistochemical localization of CA IV in EDL also yielded specific staining of capillaries. Figures 4a and 4b show sections of EDL after anti-CA IVlFITC treatment or non-immune serumlFITC incubation, respectively. Since between soleus and EDL all three main fiber types of rat muscle, slow oxidative, fast oxidative-gycolytic, and fast glycolytic, are present, these results suggest that CA IV is probably present in the capillaries of all rat skeletal muscles.
Capillary CA IV Is Accessible from the Capillary Lumen With regard to the physiological role of such a capillary CA, it was important to establish whether CA IV is anchored to the luminal surface of the capillary endothelial cells and is thus exposed to the circulation and functionally accessible from the capillary lumen. To address this question, rat hindlimbs were perfused with antiserum to CA IV or with non-immune control serum and then examined for CA IV-bound antibody. Figures 5a and 5b show sections of antiserum-and control serum-perfused soleus muscles processed for anti-rabbit IgGlFITC staining to visualize bound IgG. Figure  5a demonstrates clear fluorescence of capillaries, whereas the fluorescence in the control section (Figure 5b ) is negligible. The perfused EDL yielded the same result, although the perfusion in this muscle was less homogeneous (result not shown). This experiment shows that the enzyme is accessible to antibodies in the lumen of the capillaries during perfusion. Figure 6 shows the results of a further experiment which was carried out to evaluate how much of the total muscle CA IV is oriented towards the capillary lumen. Muscle extracts were prepared from TA muscle perfused with rabbit control serum (CS) or rabbit anti-lung CA IV serum (AS). The extracts were first treated with Staph A (first immune precipitation; Figure 6 ) to collect the im- mune complexes formed by reaction of luminal capillary CA IV with the antibody during perfusion. The supernatants from the first immunoprecipitation were then mixed with additional anti-CA IV and immune complexes were again recovered by Staph A (second immunoprecipitation; Figure 6 ). These secondarily precipitated immune complexes represent the CA IV that was not bound to the antibodies in the perfusate and was therefore not precipitated by the first Staph A treatment. The immune complexes from the first Staph A precipitation (first IP; Figure 6 ) and from the second Staph A precipitation (second IP; Figure 6 ) were analyzed by SDS-PAGE under non-reducing conditions, followed by immunoblotting. From the results in Figure 6 , it is obvious that most of the CA IV in the muscle was accessible to the antiserum during perfusion. Only a minor fraction of the enzyme had not reacted with the antibodies in the perfusate and could therefore be collected from the supernatants only by additional anti-CA IV. In the control muscle (perfused with non-immune serum), no CA IVcontaining immune complexes were recovered from the first Staph A precipitation. All the CA IV from this muscle was recovered in the second immunoprecipitation after exposure ofthe solubilized enzyme to anti-CA IV and a second Staph A treatment. From these experiments, it appears possible that more than 90% of the muscle CA IV is associated with endothelial cells and is accessible to antibodies in the capillary lumen. The localization of the CA IV that did not bind antibodies during the perfusion is not clear from the present experiments. This could be CA IV in another location, e.g., in association with SL and/or SR. or it could mean that the labeling of the intracapillary CA during the perfusion was not quantitative. If, on the other hand, unbound anti-CA IV had been left in the vascular bed, this free antibody would react with CA IV from other sites after homogenization and lead to an underestimation of extravascular CA IV. The present experiments suggest that the major portion of muscle CA IV is associated with capillaries, although a precise quantification of this portion is difficult.
CA IV in Human Muscle
Human skeletal muscles of various origins were investigated. The sections used for Figure 7 were taken from a muscle biopsy of the left forearm. Figures 7a and 7b show the same muscle section double stained with anti-CA IV/TRITC and anti-vWF/FITC. The fluorescent structures surrounding one selected cell are marked with arrows in both figures. The same sites are stained with anti-CA IV and anti-vWF. As vWF is a capillary marker, we can conclude that CA IV is located in human muscle capillaries in a similar way as in rat muscles. All muscles investigated showed the same staining pattern.
Discussion
The 29), as well as Effros and Weissman (30), observed in blood-free perfused hindlimbs of dogs and cats, respectively, that the volume of distribution for H14C03-is greatly reduced when acetazolamide is present in the perfusate. According to the latten' interpretation, an intracapillary CA is present which converts the HI4CO3-in the perfusate to 14C02, which has easy access to the entire intracellular space, and this explains the smaller volume of distribution of H14C03-in the presence than in the absence of CA inhibitors. O'Brasky and Crandall(31). using a pH stop-flow technique, also inferred an intracapillary CA from the findings that only small downstream pH changes occurred in the perfusate leaving the rabbit hindlimb but that a greater pH disequilibrium was observed when acetazolamide was present.
Geers and Gros (32), using the indicator dilution technique of Effros and Weissman (30). obtained additional evidence for the existence of an extracellular CA. Geers et al. (9) then showed in a further study that Prontosil dextran 100,000 (PD lOO, OOO), a macromolecular CA inhibitor confined to the vascular bed, failed to have an effect on 14C washout in perfused rabbit hindlimbs. By contrast, PD 5000, with access to the entire extracellular space, resulted in a marked acceleration of 14C washout. No staining of muscle capillaries could be detected with the dansylsulfonamide technique in the same study, but rather a strong staining of the sarcolemma. From these observations the authors concluded that the extracellular CA is not located intravascularly but rather is associated with the sarcolemma of muscle cells. This is in contrast to our present results. We have no clue at the moment as to why PD 100,000 did not inhibit endothelial CA in the above-mentioned study. The IgG antibodies with comparable molecular weight certainly had access to endothelial CA in the present perfusion experiments. In summary, the available results from perfusion studies indicate that in skeletal muscle there is a CA that is clearly extracellular-sarcolemmal and/or intracapillary. The results cannot be explained on the basis of an intracellular CA only.
Prior studies have suggested a CA in SR (8) (9) (10) (11) (12) and have demonstrated CA IV in SL vesicle preparations (18) . Although the evidence for CA IV in SL vesicle preparations was quite convincing (18), the present studies suggest that most of that CA IV activity was probably in endothelial plasma membrane vesicles co-pudying with the SL vesicles. Because the present perfusion experiments indicate that the portion of extravascular CA IV in muscle is small, it may not be easily detectable by the immunofluorescence method. The clear SL staining observed with the dansylsulfonamide technique (9) and with the modified Hansson technique (21-23) suggests that SL CA does exist but is not demonstrable with the present technique. Furthermore, the strong fluorescence of capillaries observed here may be due to projections of many fluorescent antigenic sites along the longitudinal axis of the capillaries. This must not be so with a system such as the SR. especially if the antigenic sites are oriented towards the interior ofthe SR (33). To obtain more information about the question of membrane-bound CA in SL and SR. further immunohistochemical studies at the EM level are under way.
With regard to the physiological role of CA IV in skeletal muscle capillaries, it is important to note that there is no CA activity in blood plasma. For this reason, the catalyzed conversion of CO2 +H2O to HCO3-+H+ has usually been assumed to take plac: exclusively inside the red blood cells. However, a luminal CA on the capillary endothelial surface could accelerate the hydration of metabolically produced CO2 in plasma and thus facilitate the buffering of protons by plasma proteins, which then would be independent of the relatively slow ionic movements across the red cell membrane (34). This activity of CA IV could increase the amount of CO2 taken up by the blood during capillary transit, an effect that may be useful for skeletal muscle function, especially during exercise.
